Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19
With the spread of the novel coronavirus disease of 2019 (COVID-19) worldwide and associated high incidence of thromboembolic complications, the use of heparin is on the rise. It therefore is crucial to identify patients with contraindications for heparin. Heparin-induced thrombocytopenia (HIT) is a life-threatening complication of exposure to heparin. We report a 66-year-old woman, who was admitted to the hospital with COVID-19 infection. Her course was complicated by pulmonary embolism and dialysis catheter thrombosis. Our patient had a known history of HIT. Treatment of this patient with heparin would have been catastrophic. The COVID-19 pandemic has overwhelmed healthcare systems and is causing a global health crisis. Nevertheless, this case serves as a reminder of the importance of making every effort to obtain thorough history and review of records of every patient.
Corresponding author: Sachin GuptaCompeting interests: No competing interests were disclosed.Grant information: The author(s) declared that no grants were involved in supporting this work.
Copyright: © 2020 Aly R et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to cite: Aly R, Gupta S, Gupta S et al. Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19 [version 1; peer review: awaiting peer review]. F1000Research 2020, 9:704 (https://doi.org/10.12688/f1000research.24974.1)
First published: 14 Jul 2020, 9:704 (https://doi.org/10.12688/f1000research.24974.1)
Latest published: 14 Jul 2020, 9:704 (https://doi.org/10.12688/f1000research.24974.1)
